Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of EVL mRNA | affects expression | 21346803
|
C035208 |
2-amino-4,6-dinitrotoluene |
2-amino-4,6-dinitrotoluene affects the expression of EVL mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of EVL mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of EVL protein | affects expression | 20106945
|
C058317 |
arsenic disulfide |
arsenic disulfide results in decreased expression of EVL mRNA | decreases expression | 12890387
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of EVL mRNA | decreases expression | 15725085
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of EVL mRNA | decreases expression | 20064835
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of EVL mRNA | increases expression | 20678512
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of EVL mRNA | increases expression | 18180321
|
C009160 |
cyclonite |
cyclonite results in increased expression of EVL mRNA | increases expression | 19417177
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of EVL mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of EVL mRNA | decreases expression | 17557909
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of EVL mRNA | decreases expression | 18035473
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of EVL mRNA | increases expression | 16807920
|
D008727 |
Methotrexate |
EVL protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D010126 |
Ozone |
Ozone results in decreased expression of EVL mRNA | decreases expression | 12763052
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EVL mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of EVL mRNA | decreases expression | 18445702
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of EVL mRNA | increases expression | 17879257
|
D014501 |
Uranium |
Uranium affects the expression of EVL mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of EVL mRNA | affects expression | 15672453
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of EVL mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-amino-4,6-dinitrotoluene |
9.09 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.09 | 12039119 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.86 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.03 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
6.90 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.90 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.90 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.60 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.40 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.42 | 15513908 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.76 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.38 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.61 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.91 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.91 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.61 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.72 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.72 | 19483382 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.78 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 18507500 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.02 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.02 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.02 | 16978400 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.60 | 15516495 16777450 18417511 17626835 14754758 18315731 19059883 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.24 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.65 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.84 | 16050911 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.72 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.72 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.72 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
8.72 | 16217749 14691202 15073043 15553829 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.72 | 16507464 17306315 15276417 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.90 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.79 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.04 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.51 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.51 | 18572023 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.53 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.82 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.82 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.82 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.96 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.96 | 17681005 17333356 15861022 11677210 16919318 17110522 16105132 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.96 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 21278247 18507500 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
2-amino-4,6-dinitrotoluene |
5.10 | 15095906 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.10 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.91 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.91 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.91 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.93 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.16 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.01 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.04 | 20191521 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.25 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2-amino-4,6-dinitrotoluene |
6.25 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.25 | 16177239 19416960 2444490 14550746 11421492 11739529 10915739 11461765 14986274 11529661 14725611 11743745 16109766 12540782 19085960 18071297 19739265 18713872 15619225 19420014 16781746 12392966 15968718 19164858 12705907 16393943 16227642 17562736 19923254 19370779 17522070 12594235 12958197 10663392 16081117 16485898 11287661 12153990 11834606 10774834 17906064 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.02 | 19426721 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.62 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.40 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.10 | 12538720 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.36 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.36 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
18.06 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.06 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.06 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.06 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.06 | 12168785 12639820 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.18 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.59 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.06 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.54 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.48 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.91 | 16221962 19772884 19176532 18467677 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.67 | 16490937 16863852 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.89 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.63 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.10 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.07 | 10903974 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.72 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.38 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.44 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.44 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.60 | 17296493 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
4.13 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.12 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.12 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.01 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.01 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.01 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
14.01 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.03 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.03 | 12371664 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.02 | 9562676 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.79 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.71 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.22 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic disulfide |
8.70 | 12421474 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
8.70 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.68 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.12 | 19850784 20471514 16467208 16968895 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.16 | 19642359 15622746 11468182 17217047 17107899 16330433 19035177 15336539 9834237 11161223 16112521 16331271 16891316 15748426 12018890 12679006 17649720 16966277 12712474 17869043 17712046 19225113 16823087 15213294 19075265 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.27 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.65 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.35 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.35 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.61 | 12969438 16610002 16611625 11587558 19784758 12587719 19460945 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.16 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
17.56 | 2125692 18177683 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
17.56 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
17.56 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.56 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.56 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.56 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.56 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.56 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.28 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
12.02 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
12.02 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
12.02 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.94 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.76 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.42 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
8.42 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.42 | 18569708 17053015 18816296 20464547 6695378 20064080 18520028 20869020 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
8.42 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.42 | 17306315 19931552 16712894 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
8.42 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.89 | 17352296 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.02 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.48 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.02 | 10496685 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.19 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.04 | 14977855 19417148 11468182 19549372 15949261 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.42 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.59 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.09 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.11 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.88 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.78 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.87 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.95 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.95 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.95 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.21 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
3.89 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.14 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.14 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.80 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.79 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.35 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.90 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.82 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.82 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.32 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.49 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.60 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.08 | 19927285 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.04 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.31 | 18381685 18929643 18007984 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.87 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.12 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.86 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.86 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.86 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.86 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.86 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.23 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.81 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.81 | 17410198 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.70 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.62 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.34 | 19058328 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.87 | 16646077 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.40 | 18551238 |
MESH:D012640 |
Seizures |
|
cyclonite |
6.40 | 19417177 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.42 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.58 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.58 | 18572023 19524636 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.86 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.73 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.35 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.35 | 20155912 2093021 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.45 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.90 | 16684133 16045194 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.95 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.54 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.07 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.02 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.88 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.64 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
11.64 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.64 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.64 | 16712894 16452187 17306315 11723127 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.23 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.89 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.69 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.93 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.21 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.46 | 15869587 14671159 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |